The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, One Medical Center Drive, Lebanon, NH, 03756, USA.
Radboud university medical center, Scientific Institute for Quality of Healthcare, PO Box 9101, Nijmegen, 6500, HB, the Netherlands.
Patient Educ Couns. 2019 May;102(5):817-841. doi: 10.1016/j.pec.2018.12.020. Epub 2018 Dec 21.
To determine the effect of encounter patient decision aids (PDAs) as evaluated in randomized controlled trials (RCTs) and conduct a narrative synthesis of non-randomized studies assessing feasibility, utility and their integration into clinical workflows.
Databases were systematically searched for RCTs of encounter PDAs to enable the conduct of a meta-analysis. We used a framework analysis approach to conduct a narrative synthesis of non-randomized studies.
We included 23 RCTs and 30 non-randomized studies. Encounter PDAs significantly increased knowledge (SMD = 0.42; 95% CI 0.30, 0.55), lowered decisional conflict (SMD= -0.33; 95% CI -0.56, -0.09), increased observational-based assessment of shared decision making (SMD = 0.94; 95% CI 0.40, 1.48) and satisfaction with the decision-making process (OR = 1.78; 95% CI 1.19, 2.66) without increasing visit durations (SMD= -0.06; 95% CI -0.29, 0.16). The narrative synthesis showed that encounter tools have high utility for patients and clinicians, yet important barriers to implementation exist (i.e. time constraints) at the clinical and organizational level.
Encounter PDAs have a positive impact on patient-clinician collaboration, despite facing implementation barriers.
The potential utility of encounter PDAs requires addressing the systemic and structural barriers that prevent adoption in clinical practice.
评估随机对照试验(RCT)中遇到的患者决策辅助工具(PDA)的效果,并对评估可行性、实用性及其纳入临床工作流程的非随机研究进行叙述性综合。
系统搜索 RCT 中使用的遇到 PDA 的数据库,以进行荟萃分析。我们使用框架分析方法对非随机研究进行叙述性综合。
我们纳入了 23 项 RCT 和 30 项非随机研究。遇到 PDA 显著提高了知识(SMD=0.42;95%置信区间 0.30,0.55),降低了决策冲突(SMD=-0.33;95%置信区间-0.56,-0.09),增加了基于观察的共享决策评估(SMD=0.94;95%置信区间 0.40,1.48)和对决策过程的满意度(OR=1.78;95%置信区间 1.19,2.66),而不会增加就诊时间(SMD=-0.06;95%置信区间-0.29,0.16)。叙述性综合表明,遇到工具对患者和临床医生具有很高的实用性,但在临床和组织层面存在重要的实施障碍(即时间限制)。
尽管面临实施障碍,但遇到 PDA 对医患合作有积极影响。
需要解决阻碍其在临床实践中应用的系统性和结构性障碍,以充分发挥遇到 PDA 的潜在实用性。